Rebeccah Brusca, MD, MPH

Assistant Professor

Dr. Rebeccah McKibben Brusca is an Assistant Clinical Professor of Medicine at University of California, San Francisco (UCSF) and an academic hospitalist at Zuckerberg San Francisco General Hospital (ZSFG). She graduated from Johns Hopkins University School of Medicine before completing her residency training at the Johns Hopkins Hospital Osler Internal Medicine Program.

Dr. Brusca is currently the Site Director for the Internal Medicine residency at ZSFG and a Bridges coach with the UCSF School of Medicine. Her academic interests include medical education, health equity and asylum medicine. She conducts forensic medical evaluations for individuals seeking asylum and is the Associate Medical Director of the UCSF Human Rights Collaborative.
2020 - Diversity, Equity, and Inclusion Champion Training, University of California, San Francisco
2018 - Internal Medicine, Johns Hopkins Hospital Osler Medical Residency
M.D., 2015 - , Johns Hopkins University School of Medicine
M.P.H., 2009 - Population, Family and Reproductive Health, University of Ghana, School of Public Health
B.A., 2008 - Chemistry, Pomona College
Honors and Awards
  • DHM Outstanding Educator Award, UCSF, 2022
  • SOM Excellence in Teaching Award, UCSF, 2022
  • Distinguished Teaching Society, Johns Hopkins University School of Medicine, 2018
  • Henry Strong Denison Research Scholar Award, Johns Hopkins University School of Medicine, 2015
  • American Heart Association Predoctoral Fellowship, American Heart Association, 2013
  • Rotary Ambassadorial Scholarship, Rotary Club, 2008
  1. Hidden

    Brusca RM, Hanna DB, Wada NI, Blankson JN, Witt MD, Jacobson LP, Kingsley L, Palella FJ, Budoff M, Brown TT, Anastos K, Lazar JM, Mack WJ, Bacchetti P, Tien PC, Golzar Y, Plankey M, Golub E, Kaplan RC, Post WS. Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations. 2019. PMID: 31729142

  2. Hidden
    Journal of intensive care medicine

    Brusca RM, Simpson CE, Sahetya SK, Noorain Z, Tanykonda V, Stephens RS, Needham DM, Hager DN. Performance of Critical Care Outcome Prediction Models in an Intermediate Care Unit. Volume 35 of Issue 12. Journal of intensive care medicine 2019. PMID: 31635507

  3. Hidden
    PloS one

    Subramanya V, McKay HS, Brusca RM, Palella FJ, Kingsley LA, Witt MD, Hodis HN, Tracy RP, Post WS, Haberlen SA. Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study. Volume 14 of Issue 4. PloS one 2019. PMID: 30946765

  4. Hidden
    Respiratory medicine

    Brusca RM, Pinal-Fernandez I, Psoter K, Paik JJ, Albayda J, Mecoli C, Tiniakou E, Mammen AL, Christopher-Stine L, Danoff S, Johnson C. The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease. Volume 150. Respiratory medicine 2019. PMID: 30961952

  5. Hidden

    Brusca RM, Griffin JM, Miller K, Russell SD. Metastatic amelanotic melanoma with cardiac involvement: A case report. Volume 19 of Issue 2. 2018. PMID: 31193670

  6. Hidden

    Palella FJ, McKibben R, Post WS, Li X, Budoff M, Kingsley L, Witt MD, Jacobson LP, Brown TT. Anatomic Fat Depots and Coronary Plaque Among Human Immunodeficiency Virus-Infected and Uninfected Men in the Multicenter AIDS Cohort Study. Volume 3 of Issue 2. 2016. PMID: 27419170

  7. Hidden

    McKibben RA, Al Rifai M, Mathews LM, Michos ED. Primary Prevention of Atherosclerotic Cardiovascular Disease in Women. Volume 10. 2015. PMID: 28149430

  8. Hidden
    Journal of acquired immune deficiency syndromes (1999)

    Ketlogetswe KS, McKibben R, Jacobson LP, Li X, Dobs AS, Budoff M, Witt MD, Palella FJ, Kingsley L, Margolick JB, Post WS, Brown TT. Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-?B Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. Volume 70 of Issue 4. Journal of acquired immune deficiency syndromes (1999) 2015. PMID: 26090754

  9. Hidden

    Martin SS, Feldman DI, Blumenthal RS, Jones SR, Post WS, McKibben RA, Michos ED, Ndumele CE, Ratchford EV, Coresh J, Blaha MJ. mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity Promotion. Volume 4 of Issue 11. 2015. PMID: 26553211

  10. Hidden

    McKibben RA, Zhao D, Lutsey PL, Schneider AL, Guallar E, Mosley TH, Michos ED. Factors Associated With Change in 25-Hydroxyvitamin D Levels Over Longitudinal Follow-Up in the ARIC Study. Volume 101 of Issue 1. 2015. PMID: 26509869

  11. Hidden
    The Journal of infectious diseases

    McKibben RA, Haberlen SA, Post WS, Brown TT, Budoff M, Witt MD, Kingsley LA, Palella FJ, Thio CL, Seaberg EC. A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study. Volume 213 of Issue 2. The Journal of infectious diseases 2015. PMID: 26216904

  12. Hidden

    McKibben RA, Pitts SI, Suarez-Cuervo C, Perl TM, Bass EB. Practices to Reduce Surgical Site Infections Among Women Undergoing Cesarean Section: A Review. Volume 36 of Issue 8. 2015. PMID: 25990701

  13. Hidden
    The Journal of infectious diseases

    McKibben RA, Margolick JB, Grinspoon S, Li X, Palella FJ, Kingsley LA, Witt MD, George RT, Jacobson LP, Budoff M, Tracy RP, Brown TT, Post WS. Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection. Volume 211 of Issue 8. The Journal of infectious diseases 2014. PMID: 25362192

  14. Hidden

    Taylor JL, McKibben RA, DeCamp M, Chisolm MS. Putting a face on the prescription opioid epidemic: a case report. Volume 36 of Issue 4. 2014. PMID: 24745324

  15. Hidden

    Gormally MV, McKibben RK, Johal MS, Selassie CR. Controlling tyrosinase activity on charged polyelectrolyte surfaces: a QCM-D analysis. Volume 25 of Issue 17. 2009. PMID: 19505131

  16. Hidden
    American journal of medical genetics

    Strom CM, Brusca RM, Pizzi WJ. Double-blind, placebo-controlled crossover study of folinic acid (Leucovorin for the treatment of fragile X syndrome. Volume 44 of Issue 5. American journal of medical genetics 1992. PMID: 1481832